Researcher
Karim Vermaelen
- Keywords:immunology, Immuno-oncology, oncology, respiratory medicine
- Disciplines:Immunology not elsewhere classified , Cancer therapy , Immunology not elsewhere classified, Cancer biology, Applied immunology, Applied immunology , Immunomodulation therapy, Respiratory medicine, Cell therapy, Vaccinology, Oncology not elsewhere classified, Medical transcriptomics
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → Today - Department of Internal medicine (Department)
Member
From1 Jan 1998 → 30 Sep 2018
Projects
1 - 10 of 27
- HIGH-THROUGHPUT, HIGH-SENSITIVITY AND COST-EFFECTIVE MONITORING OF INNATE AND ADAPTIVE IMMUNE RESPONSES AT SINGLE CELL LEVELFrom15 Dec 2022 → TodayFunding: BOF - scientific equipment program
- A patient derived xenograft (PDX) platform for in vivo evaluation of novel anticancer therapiesFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- BioGelator for local immunotherapyFrom15 Jul 2021 → TodayFunding: IOF - technology validation in lab
- Proteomics-derived epitopes for dramatically improved anticancer and antibacterial vaccine developmentFrom1 Jan 2021 → TodayFunding: BOF - projects
- SparXellsU+2122 : Enabling Next-Generation Dendritic Cell Therapy in Lung cancer and BeyondFrom15 Oct 2020 → 31 Dec 2022Funding: IOF - technology validation in real environment
- Non-invasive prediction of immune-therapy response in lung cancer patients (NIPIT)From1 Oct 2020 → TodayFunding: Nonprofit institution or equivalents
- Development of a non-invasive test to predict immunotherapy response in lung cancer patientsFrom1 Oct 2020 → TodayFunding: FWO junior postdoctoral fellowship
- IP strenghtening for MIDRIX, a unique manufacturing process for dendritic cell immunotherapy in solid cancersFrom1 Apr 2019 → 31 Aug 2020Funding: IOF - technology concept exploration
- Immunomonitoring of patients with non-small cell lung carcinoma treated with a tumor mutanome-targeted dendritic cell vaccineFrom1 Jan 2018 → 31 Dec 2021Funding: BOF - Doctoral projects
- Improving outcome of immune checkpoint blockade in lung cancer by combination with a tumor mutanome-targeted dendritic cell vaccineFrom1 Jan 2017 → 31 Dec 2021Funding: Nonprofit institution or equivalents
Publications
1 - 10 of 65
- Headspace volatile organic compound profiling of pleural mesothelioma and lung cancer cell lines as translational bridge for breath research(2022)
Authors: Eline Janssens, Zoë Mol, Lore Vandermeersch, Sabrina Lagniau, Karim Vermaelen, Jan Van Meerbeeck, Christophe Walgraeve, Elly Marcq, Kevin Lamote
- Application of an ultrasensitive NGS-based blood test for the diagnosis of early-stage lung cancer : sensitivity, a hurdle still difficult to overcome(2022)
Authors: Malaïka Van der Linden, Bram Van Gaever, Lennart Raman, Karim Vermaelen, Ingel Demedts, Veerle Surmont, Ulrike Himpe, Yolande Lievens, Liesbeth Ferdinande, Franceska Dedeurwaerdere, et al.
- Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation : a case report(2021)
Authors: Lander Van Acker, Dieter Stevens, Karim Vermaelen, Veerle Surmont
- The RNA Atlas expands the catalog of human non-coding RNAs (June, 10.1038/s41587-021-00936-1, 2021)(2021)
Authors: Lucia Lorenzi, Hua-Sheng Chiu, Francisco Avila Cobos, Stephen Gross, Pieter-Jan Volders, Robrecht Cannoodt, Justine Nuytens, Katrien Vanderheyden, Jasper Anckaert, Steve Lefever, et al.
Pages: 1467 - 1467 - Dendritic cell-based immunotherapy in lung cancer(2021)
Authors: Dieter Stevens, Joline Ingels, Sandra Van Lint, Bart Vandekerckhove, Karim Vermaelen
- Treatment of a patient with severe cytomegalovirus (CMV) infection after haploidentical stem cell transplantation with donor-derived CMV-specific T cells(2021)
Authors: Joline Ingels, Saskia De Smet, Kelly Heyns, Nele Lootens, Jonas Segaert, Tom Taghon, Georges Leclercq, Karim Vermaelen, Evelyne Willems, Etienne Baudoux, et al.
Pages: 482 - 486 - Managing viral hepatitis in cancer patients under immune checkpoint inhibitors : should we take the risk?(2021)
Authors: Stijn De Keukeleire, Tijl Vermassen, Zahra Mosala Nezhad, Tessa Kerre, Vibeke Kruse, Hans Van Vlierberghe, Karim Vermaelen, Sylvie Rottey
Pages: 409 - 418 - mRNA in cancer immunotherapy : beyond a source of antigen(2021)
Authors: Lien Van Hoecke, Rein Verbeke, Heleen Dewitte, Sabine Lentacker, Karim Vermaelen, Karine Breckpot, Sandra Van Lint
- Chitosan/U+03B3-PGA nanoparticles-based immunotherapy as adjuvant to radiotherapy in breast cancer(2020)
Authors: Flávia Castro, Marta L. Pinto, Catarina L. Pereira, Karine Serre, Mário A. Barbosa, Karim Vermaelen, Fátima Gärtner, Raquel M. Gonçalves, Olivier De Wever, Maria J. Oliveira
- Blood-based test for diagnosis and functional subtyping of familial Mediterranean fever(2020)
Authors: Hanne Van Gorp, Linyan Huang, Pedro Henrique Viana Saavedra, Marnik Vuylsteke, Tomoko Asaoka, Giusi Prencipe, Antonella Insalaco, Benson Ogunjimi, Jerold Jeyaratnam, Ilaria Cataldo, et al.
Pages: 960 - 968